Antiaggregant preparation "Plavix": instructions for use

The drug "Plavix" instructions for use characterizes as an antiaggregant drug, which has a pronounced coronary-damaging effect. Regular reception of this drug effectively prevents the development of atherothrombosis. In this case, Plavix demonstrates good results both in coronary and cerebral or peripheral lesions of the arteries. This antiplatelet agent is based on the suppression of platelet aggregation, which begins to be observed from the first day of admission and gradually increases over the next three to seven days. Subsequently, this indicator, as a rule, reaches a constant level.

The antiaggregant preparation "Plavix" is issued (the instruction on application is always included) in the form of oblong tablets of pink color. The composition of each dragee as the main active ingredient is clopidogrel. In the role of auxiliary elements are low-substituted giprolose, macrogol 6000, mannitol, castor oil, microcrystalline cellulose, lactose monohydrate, titanium dioxide, triacetin, hypromellose, red iron oxide and carnauba wax.

Take the tablet "Plavix" instruction for use is mainly recommended to prevent ischemic disorders. For example, this antiaggregant drug may be prescribed for the prevention of peripheral thrombosis of arteries. To prevent stroke in patients with atherosclerosis, it is also recommended to use the drug "Plavix". Its use is shown for the prevention of myocardial infarction. In addition, this drug can be used in combination with vitamin C to prevent atherothrombosis in people with acute coronary syndrome.

Prescribe an antiaggregant drug "Plavix" instruction for use is not recommended in the event that the patient has a deficiency of lactase, hereditary intolerance to galactose or severe hepatic insufficiency. In addition, do not start taking these pills for any acute bleeding, for example, with intracranial hemorrhage.

The list of direct contraindications also includes the lactation period, pregnancy and hypersensitivity to clopidogrel. In addition, do not prescribe this antiplatelet agent to people under the age of eighteen. With extreme caution use the drug "Plavix" with renal failure, moderate form of liver failure, as well as with injuries, various kinds of surgical interventions and diseases associated with a predisposition to the development of bleeding.

The most common adverse reactions associated with taking this antiplatelet drug are neutropenia, dyspepsia and thrombocytopenia. In addition, the risk of gastrointestinal bleeding, the development of hemorrhagic stroke, gastritis and ulceration of the gastrointestinal mucosa are quite high. Also, some patients complain of diarrhea, constipation and abdominal pain.